Market Overview

McDermott Wins EPCI Project for Four Jackets Offshore Qatar

Share:

McDermott International, Inc. (NYSE: MDR) today announced it has been awarded a sizeable brownfield project by Qatar Petroleum for the engineering, procurement, construction and installation (EPCI) of four wellhead jackets.

McDermott has been awarded a sizeable brownfield offshore project by Qatar Petroleum for the enginee ...
McDermott has been awarded a sizeable brownfield offshore project by Qatar Petroleum for the engineering, procurement, construction and installation (EPCI) of four wellhead jackets, similar to this file photograph. (Photo: Business Wire)
Installation of two jackets in the Bul-Hanine field offshore east of Doha has been scheduled to be completed by December 2016 with the remaining two scheduled for completion in July 2017. The total weight of all four structures combined is 3,495 tons.

"McDermott's integrated EPCI capabilities are critical to these offshore projects," said Tom Mackie, McDermott's Vice President, Middle East. "This award is another example of collaboration with our customers to meet their critical production and project requirements. The award is expected to be executed with McDermott's internal resources and backed by our proven track record of designing, building and installing offshore and subsea solutions."

Revenue for the order will be included in McDermott's third quarter 2015 backlog.

McDermott has been delivering projects in Qatar for more than 40 years. Detailed design engineering and procurement is expected to be performed by McDermott's teams in Dubai, U.A.E. Jackets are scheduled for fabrication by McDermott's Dubai, U.A.E.-based fabrication facility. Vessels from the McDermott global fleet are scheduled to undertake the installation work.

Posted-In: News Press Releases

 

Related Articles (MDR)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

CoLucid Pharmaceuticals Announces Initiation of Phase 3 Long-Term, Open-Label Trial of Lasmiditan in Migraine

AstraZeneca Presents Respiratory Syncytial Virus (RSV) Study Results at IDWeek 2015